2026 MedTech Industry Guide

    5 Best MedTech Market Research Firms in China (2026 Rankings)

    A ranked comparison of MedTech and medical devices market research firms serving China in 2026. For regional context, start from the healthcare market research hub and healthcare market research in China.

    For company-intent programmes, see our MedTech market research company in China page and the China market intelligence briefing.

    Top MedTech market research firms in China (2026)

    1. 1BioNixus — International MedTech Specialist
    2. 2IQVIA — Global Life Sciences Data
    3. 3Kantar — Global Network
    4. 4Ipsos — Global Network
    5. 5Regional specialist agencies — Local / Regional

    The China MedTech research landscape in 2026

    The China medical devices market is estimated at USD 80–95 billion in 2026, shaped by NMPA regulation, hospital procurement cycles, and Thousands of domestic manufacturers; import share declining in commodity segments. Manufacturers launching or defending device portfolios need primary research that maps prescriber behaviour to committee and payer reality — not syndicated averages alone.

    MedTech market research in China differs from pharmaceutical research: sample frames prioritise biomedical engineers, hospital value-analysis committees, and procedure specialists; evidence must address total cost of ownership, training burden, and maintenance contracts alongside clinical efficacy.

    Global syndicated vendors provide audit data; specialist firms like BioNixus add verified hospital access, NMPA-aware study design, and decision-linked synthesis for launch sizing, competitive defence, and international expansion planning.

    For company-intent programmes — not firm comparison — see our dedicated MedTech market research page for China. For broader healthcare context, start from the healthcare market research hub and /healthcare-market-research-china.

    1

    BioNixus

    International MedTech Specialist · USA (HQ) / UK / Egypt

    BioNixus delivers MedTech and medical devices market research in China with NMPA-aware hospital procurement research, clinician adoption studies, and decision-ready synthesis. See the dedicated company page at /china-medtech-market-research.

    • MedTech programmes in China
    • Mandarin Chinese (English for multinational HQ programmes) fieldwork where required
    • Hospital procurement and KOL depth
    • Mixed quant + qual design
    • GCC expansion intelligence for international manufacturers

    View BioNixus MedTech market research in China

    2

    IQVIA

    Global Life Sciences Data · USA (global)

    IQVIA provides medical device market analytics, hospital audit data, and custom primary research in China through its global life sciences network.

    • Syndicated device audit data
    • Global benchmarking
    • Large-scale quant infrastructure
    3

    Kantar

    Global Network · UK (global)

    Kantar operates custom and syndicated research in China with healthcare and B2B practices supporting MedTech brand tracking and physician insight programmes.

    • Brand tracking at scale
    • Multi-sector coverage
    • Established field networks
    4

    Ipsos

    Global Network · France (global)

    Ipsos delivers healthcare and device market research in China with quantitative rigour and public affairs capability for regulated categories.

    • Healthcare specialty practice
    • Quantitative rigour
    • Global methodology standards
    5

    Regional specialist agencies

    Local / Regional · China and international

    Several regional boutiques execute MedTech fieldwork in China. Validate device-specific methodology, hospital access, and NMPA context before award.

    • Local hospital networks
    • Flexible project sizing
    • Fast feasibility checks

    MedTech market research in China — frequently asked questions

    What are the top MedTech market research companies in China?

    Leading options include BioNixus, IQVIA, Kantar, Ipsos, and regional specialist agencies serving China. BioNixus ranks first for NMPA-aware hospital procurement research and clinician adoption studies.

    How do I choose a MedTech market research partner in China?

    Validate hospital access, device category experience, sample verification controls, regulatory context, and decision-ready deliverables — not slide volume alone.

    How does this list relate to pharmaceutical market research in China?

    This guide covers MedTech and medical devices industry selection. For pharmaceutical company-intent pages, use /healthcare-market-research-china and related healthcare BOFU URLs.

    Where is the BioNixus MedTech services page for China?

    See /china-medtech-market-research for company-intent MedTech market research programmes; this listicle compares firms independently.

    Can MedTech research in China connect to GCC benchmarking?

    Yes. BioNixus runs parallel modules comparing local adoption with SFDA, MOHAP, and GCC hospital procurement intelligence using harmonised instruments.

    What device segments do China research firms typically cover?

    Cardiovascular, orthopaedics, diagnostic imaging, IVD, diabetes technology, surgical robotics, wound care, and hospital capital equipment — segment feasibility should be validated at proposal stage.

    How long does a typical MedTech study take in China?

    Focused HCP surveys complete in four to six weeks; full mixed-method programmes with hospital procurement depth typically run eight to twelve weeks depending on specialty and geography.

    Is this China MedTech firms guide updated for 2026?

    Yes. Rankings and capability notes reflect China regulatory and procurement context as of 2026, including NMPA requirements.

    Related market intelligence

    Compare MedTech research needs with our pages for Japan and Singapore, or explore the global healthcare market research hub.

    Discuss your China pharmaceutical research strategy

    Our team supports pharmaceutical companies with decision-ready insights across the Americas, Europe, and the Middle East using quantitative and qualitative methodologies.

    Request a proposalEmail us

    US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323

    Request a proposal